From: Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
Entire cohort | Serous carcinomas | |||||||
---|---|---|---|---|---|---|---|---|
IGKC | CD20 | CD138 | PIGR | IGKC | CD20 | CD138 | PIGR | |
IGKC | ||||||||
R | 0.257** | 0.196* | 0.008 | 0.237* | 0.113 | −0.027 | ||
p | 0.001 | 0.017 | 0.923 | 0.025 | 0.297 | 0.805 | ||
n | 151 | 148 | 150 | 89 | 87 | 89 | ||
CD20 | ||||||||
R | 0.257** | 0.171* | −0.167* | 0.237* | 0.126 | −0.083 | ||
p | 0.001 | 0.036 | 0.039 | 0.025 | 0.244 | 0.439 | ||
n | 151 | 151 | 153 | 89 | 88 | 90 | ||
CD138 | ||||||||
R | 0.196* | 0.171* | −0,087 | 0.113 | 0.126 | 0.100 | ||
p | 0.017 | 0.036 | 0.292 | 0.297 | 0.244 | 0.356 | ||
n | 148 | 151 | 150 | 87 | 88 | 88 |